Extracellular domain ERBB2 (ERBB2 ECD+) mutations in urothelial bladder cancer (UBC).

被引：0
|
作者：
Basin, Michael
Jacob, Joseph M.
Bratslavsky, Gennady
Grivas, Petros
Spiess, Philippe E.
Li, Roger
Necchi, Andrea
Pavlick, Dean C.
Huang, Richard S. P.
Lin, Douglas I.
Danziger, Natalie
Sokol, Ethan
Sivakumar, Smruthy
Ross, Jeffrey S.
机构：
[1] SUNY Upstate Med Univ, Syracuse, NY USA
[2] Univ Washington, Div Oncol, Dept Med,Seattle Canc Care Alliance, Fred Hutchinson Canc Res Ctr, Seattle, WA USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] Univ Vita Salute San Raffaele, Milan, Italy
[5] IRCCS San Raffaele Hosp & Sci Inst, Dept Med Oncol, Milan, Italy
[6] Fdn Med Inc, Cambridge, MA USA
[7] Fdn Med Inc, Morrisville, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
566
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Genomic Landscape and Clinical Features of Carcinomas with ERBB2 S310 Extracellular Domain Mutations
    Desmeules, Patrice
    Zehir, Ahmet
    Hyman, David M.
    Arcila, Maria E.
    Ladanyi, Marc
    MODERN PATHOLOGY, 2017, 30 : 456A - 456A
  • [42] Effect of Erbb2 Missense Mutations on Dimer Formation
    Cano, Tayde Gabriela Serrano
    Yasari, Atena
    Tiemann-Boege, Irene
    Nagy, Peter
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2023, 52 (SUPPL 1): : S105 - S105
  • [43] Landscape of somatic ERBB2 Mutations: Findings from AACR GENIE and comparison to ongoing ERBB2 mutant basket study
    Schram, Alison
    Won, Helen H.
    Andre, Fabrice
    Arnedos, Monica
    Meric-Bernstam, Funda
    Bedard, Philippe L.
    Shaw, Kenna R.
    Horlings, Hugo
    Micheel, Christine
    Park, Ben Ho
    Mann, Grace
    Lalani, Alshad S.
    Smyth, Lillian
    Solit, David B.
    Schrag, Deborah
    Levy, Mia A.
    Rollins, Barrett J.
    Routbort, Mark
    Sawyers, Charles L.
    Lepisto, Eva
    Berger, Michael F.
    Hyman, David M.
    CANCER RESEARCH, 2017, 77
  • [44] ErbB2: a therapeutic target in gastric cancer
    Belle, S.
    Ebert, M. P.
    GASTROENTEROLOGE, 2012, 7 (01): : 8 - 13
  • [45] Role of erbB2 in breast cancer chemosensitivity
    Yu, DH
    Hung, MC
    BIOESSAYS, 2000, 22 (07) : 673 - 680
  • [46] Targeting ERBB2 pathway in ovarian cancer
    Kovtun, Irina, V
    Zhang Piyan
    Harris, Faye R.
    Hou, Xiaonan
    Weroha, Saravut J.
    Vasmatzis, George
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [47] ErbB2 diagnostics in breast cancer - an update
    Rueschoff, J.
    Nagelmeier, I.
    Hofmann, M.
    Henkel, Th.
    Stoss, O.
    PATHOLOGE, 2009, 30 (02): : 147 - 155
  • [48] Lack of somatic ErbB2 tyrosine kinase domain mutations in hepatocellular carcinoma
    Wong, Chiung-Ing
    Yap, Hui-Ling
    Lim, Seng-Gee
    Guo, Jia-Yi
    Goh, Boon-Cher
    Lee, Soo-Chin
    HEPATOLOGY RESEARCH, 2008, 38 (08) : 838 - 841
  • [49] Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas
    Lee, JW
    Soung, YH
    Seo, SH
    Kim, SY
    Park, CH
    Wang, YP
    Park, K
    Nam, SW
    Park, WS
    Kim, SH
    Lee, JY
    Yoo, NJ
    Lee, SH
    CLINICAL CANCER RESEARCH, 2006, 12 (01) : 57 - 61
  • [50] Oncogenic Addiction to ERBB2 Signaling Predicts Response to Trastuzumab in Urothelial Cancer
    Karass, Michael
    Bareja, Rohan
    Shelkey, Ethan
    Vlachostergios, Panagiotis J.
    Robinson, Brian D.
    Khani, Francesca
    Mosquera, Juan Miguel
    Scherr, Douglas S.
    Sboner, Andrea
    Tagawa, Scott T.
    Molina, Ana M.
    Elemento, Olivier
    Nanus, David M.
    Faltas, Bishoy M.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (03): : 194 - 200
12345